Alessandra Bura Rivière (Alessandra Bura-Rivière)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Aortic Aneurysm

Vascular Endothelial Growth Factor

Oral Anticoagulants

Top Venues

EMBO molecular medicine

European journal of clinical pharmacology

British journal of clinical pharmacology

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Justine Creff, Asalaa Lamaa, Emeline Benuzzi, Elisa Balzan, Francoise Pujol, Tangra Draia-Nicolau, Manon Nougué, Lena Verdu, Florent Morfoisse, Eric Lacazette, Philippe Valet, Benoit Chaput, Fabian Gross, Regis Gayon, Pascale Bouillé, Julie Malloizel-Delaunay, Alessandra Bura Rivière, Anne-Catherine Prats, Barbara Garmy-Susini
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. EMBO molecular medicine 16 (2) (2024)
Justine Creff, Asalaa Lamaa, Emeline Benuzzi, Elisa Balzan, Francoise Pujol, Tangra Draia-Nicolau, Manon Nougué, Lena Verdu, Florent Morfoisse, Eric Lacazette, Philippe Valet, Benoit Chaput, Fabian Gross, Regis Gayon, Pascale Bouillé, Julie Malloizel-Delaunay, Alessandra Bura Rivière, Anne-Catherine Prats, Barbara Garmy-Susini
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. EMBO molecular medicine (2024)
Jean-Louis Montastruc, Alessandra Bura Rivière
Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study. British journal of clinical pharmacology (2024)
Justine Creff, Asalaa Lamaa, Emeline Benuzzi, Elisa Balzan, Francoise Pujol, Tangra Draia-Nicolau, Manon Nougué, Lena Verdu, Florent Morfoisse, Eric Lacazette, Philippe Valet, Benoit Chaput, Fabian Gross, Regis Gayon, Pascale Bouillé, Julie Malloizel-Delaunay, Alessandra Bura Rivière, Anne-Catherine Prats, Barbara Garmy-Susini
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. EMBO molecular medicine 16 (2) (2024)
Justine Creff, Asalaa Lamaa, Emeline Benuzzi, Elisa Balzan, Francoise Pujol, Tangra Draia-Nicolau, Manon Nougué, Lena Verdu, Florent Morfoisse, Eric Lacazette, Philippe Valet, Benoit Chaput, Fabian Gross, Regis Gayon, Pascale Bouillé, Julie Malloizel-Delaunay, Alessandra Bura Rivière, Anne-Catherine Prats, Barbara Garmy-Susini
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. EMBO molecular medicine 16 (2) (2024)
Jean-Louis Montastruc, Alessandra Bura Rivière
Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study. British journal of clinical pharmacology 90 (6) (2024)
Lucia Mazzolai, Gisela Teixidó, Stefano Lanzi, Vinko Boc, Eduardo Bossone, Marianne Brodmann, Alessandra Bura Rivière, Julie De Backer, Sebastien Deglise, Alessandro Della Corte, Christian Heiss, Marta Kaluzna-Oleksy, Donata Kurpas, Carmel M McEniery, Tristan Mirault, Agnes A Pasquet, Alex Pitcher, Hannah A I Schaubroeck, Oliver Schlager, Per Anton Sirnes, Muriel G Sprynger, Eugenio Stabile, Françoise Steinbach, Matthias Thielmann, Roland R J van Kimmenade, Maarit A Venermo, José F Rodriguez Palomares, null null
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European heart journal (2024)
Justine Creff, Asalaa Lamaa, Emeline Benuzzi, Elisa Balzan, Francoise Pujol, Tangra Draia-Nicolau, Manon Nougué, Lena Verdu, Florent Morfoisse, Eric Lacazette, Philippe Valet, Benoit Chaput, Fabian Gross, Regis Gayon, Pascale Bouillé, Julie Malloizel-Delaunay, Alessandra Bura Rivière, Anne-Catherine Prats, Barbara Garmy-Susini
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. EMBO molecular medicine 16 (2) (2024)
Justine Creff, Asalaa Lamaa, Emeline Benuzzi, Elisa Balzan, Francoise Pujol, Tangra Draia-Nicolau, Manon Nougué, Lena Verdu, Florent Morfoisse, Eric Lacazette, Philippe Valet, Benoit Chaput, Fabian Gross, Regis Gayon, Pascale Bouillé, Julie Malloizel-Delaunay, Alessandra Bura Rivière, Anne-Catherine Prats, Barbara Garmy-Susini
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. EMBO molecular medicine (2024)
Jean-Louis Montastruc, Alessandra Bura Rivière
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study. European journal of clinical pharmacology 80 (2) (2023)
Jean-Louis Montastruc, Alessandra Bura Rivière
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study. European journal of clinical pharmacology (2023)
Jean-Louis Montastruc, François Montastruc, Alessandra Bura Rivière
Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study. European journal of clinical pharmacology (2023)
Jean-Louis Montastruc, Alessandra Bura Rivière
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study. European journal of clinical pharmacology 80 (2) (2023)
Lucia Mazzolai, Adriano Alatri, Alessandra Bura Rivière, Marco De Carlo, Christian Heiss, Christine Espinola-Klein, Oliver Schlager, Henrik Sillesen, Daniel Staub, José F Rodriguez Palomares, Aline Verstraeten, Victor Aboyans, null null
Progress in aorta and peripheral cardiovascular disease research. Cardiovascular research 117 (9) (2021)